Morning Market Gainers

shares jumped 59.34 percent to $1.45 following the Thursday's FDA approval of hypoactive sexual desire disorder treatment for women, flibanserin.

shares gained 14.95 percent to $9.29 after the company announced the receipt of a "going private" proposal from its CEO at $9.69 per ADS or $1.938 per ordinary share.

shares climbed 10.53 percent to $2.94 after the company reported services contracts worth over $1.5 million.

shares rose 6.21 percent to $35.93 after the company reported stronger-than-expected results for the first quarter.

gained 5.63 percent to $30.60 after the company reported better-than-expected earnings for its fiscal third quarter.

shares surged 4.68 percent to $19.03. IDT reported Q3 adjusted earnings of $0.43 per share on revenue of $383.9 million.

shares climbed 4.53 percent to $7.38. SeaChange reported a Q1 loss of $0.29 per share on revenue of $23.2 million.